GrowBLOX Sciences Receives Nevada State Approval


Ryan Allway

November 6th, 2014

News, Top Story


[stockchart symbol=GBLX]

GrowBLOX Sciences, Inc., (“GB Sciences”) (GBLX), announced today that its majority-controlled Nevada applicant, GB Sciences Nevada, LLC, has received Nevada State approval to proceed with its special use permit to establish and operate a medical marijuana cultivation facility in Clark County.

GB Sciences Nevada did not receive approval from the State of Nevada for two dispensaries for which it had received approvals from Clark County and The City of Las Vegas. This puts the Company in a position similar to others who received state approval, but were denied or not yet approved by one or both of the other jurisdictions. It is unclear when, how, or if the inconsistencies between the state, city and county approvals will ultimately be resolved. While it would have been beneficial to have received the state dispensary approvals at this time, it does not detract from GB Sciences’ primary mission.

“Although we do not mean to understate the immediate commercial value of the cultivation license we were granted, our primary focus in obtaining the license was to enable the clinical research efforts we have planned, and to continue our other research initiatives into plant genetics, curing techniques, and the development of strains that are effective for particular diseases,” said GB Sciences, Inc., CEO Craig Ellins. “Without the license that was granted today, we could not pursue our mission of providing safe, consistent medication for the literally thousands of patients who need it. As a biopharmaceutical company, GB Sciences will create value through developing, patenting and branding innovative treatments; especially in ‘orphan’ disease categories where the ill have few if any treatment options.”

GB Sciences’ Chief Science Officer Dr. Andrea Small-Howard believes that through its operations in Nevada, GB Sciences can focus on:

1) Creating safe, consistent medical-grade cannabis using its proprietary GrowBLOX(TM) technology suite at their Clark County cultivation facility

2) Providing a range of personalized cannabinoid therapies that address specific medical indications

3) Continuously improving the effectiveness of its cannabinoid therapy programs through its clinical trial app (GBLX-PRO)

“Each of these three GB Sciences initiatives will be essential for providing safe and effective cannabinoid therapies for our patients,” said Dr. Small-Howard. “This is a really good day for GB Sciences’ shareholders and a great day for the people and patients of the State of Nevada.”

GB Sciences approved cultivation facility for development in Nevada is:

GB Sciences Las Vegas Cultivation Facility

This 28,432-square-foot facility will contain 20,000 square feet of cultivation space to house GB Sciences’ proprietary technology system for growing medical-grade cannabis in the TissueBLOX(TM) (for immature plantlets), GrowBLOX(TM) (for mature plants), and CureBLOX(TM) (to ensure safe, efficacious drying). In addition, the facility will feature a 2,500-square-foot conversion lab for extracting and post-processing oil-based cannabinoid therapies, a security control room, a packaging room, employee facilities, and management offices.

About GrowBLOX Sciences, Inc.

GB Sciences combines state-of-the-art technologies in plant biology, cultivation technology, and post-production processes to optimize safety and consistent quality in medicinal cannabis therapeutic products. The company is pioneering technology, industry-leading processes, and a big-data-driven clinical research and development algorithm to bring relief to patients in communities across the country.

To learn more about GB Sciences, Inc., go to: http://www.gbsciences.com.

Forward-Looking Statements

Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company’s ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management’s ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company’s filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.



Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading